Neuberger Berman is an independent and employee-controlled asset management company, providing global investment solutions.
Business Model:
Revenue: $2B
Employees: 1,001-5,000
Neuberger Berman Group was acquired by
Lehman Brothers.
The acquisition happend on 2003-11-07.
Details of the transaction were not public
Address: 1290 Avenue of the Americas
City: New York
State: NY
Zip: 10104
Country: US
Neuberger Berman is an independent and employee-controlled asset management company, providing global investment solutions. Neuberger Berman provides a broad range of global investment solutions to institutions and individuals through customized separately managed accounts, mutual funds, and alternative investment products. It was founded in 1939 and headquartered in New York, United States.
Contact Phone:
+18002236448
Contact Email:
Listed Exchange:
NYSE
IPO Date:
10/7/1999
Ticker Symbol:
NEU
IPO Price:
$32/share
Amount Raised:
$232M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2019 | Druva | Series G | 0 |
12/2020 | IOU Financial | Post-IPO Equity | 2.1M |
4/2021 | Druva | Series H | 147M |
7/2016 | CommonBond | Series C | 30M |
6/2018 | Uniasselvi | Private Equity Round | 100M |
11/2022 | Prosper Marketplace | Debt Financing | 75M |
8/2021 | Rocket Lab | Post-IPO Equity | 0 |
2/2016 | Engineering Ingegneria Informatica | Post-IPO Equity | - |
8/2022 | USIC | Secondary Market | 0 |
5/2023 | NomuPay | Series A | 53.6M |
8/2021 | Branch | Debt Financing | 500M |
1/2021 | Paycor | Private Equity Round | 0 |
7/2016 | Concord Biotech | Private Equity Round | - |
5/2021 | Constellation Automotive Group | Private Equity Round | 1.4B |
2/2021 | Koalafi | Debt Financing | - |
7/2018 | LegalZoom | Secondary Market | 0 |
7/2021 | Sunlight Financial | Post-IPO Equity | 250M |
7/2021 | Finnish Long Drink | Funding Round | 25M |
11/2016 | Velocidi | Series A | 0 |
6/2021 | PLAYSTUDIOS | Post-IPO Equity | 250M |
8/2022 | Ribbon Communications | Post-IPO Equity | 52M |
7/2021 | Lucid Motors | Post-IPO Equity | 0 |
9/2022 | Oportun | Post-IPO Debt | 150M |
7/2021 | EVgo | Post-IPO Equity | 400M |
10/2022 | Arctic Wolf | Convertible Note | 401M |
3/2021 | Fanatics | Private Equity Round | 320M |
5/2015 | Basis Technologies | Series B | 30M |
3/2021 | ChargePoint | Post-IPO Equity | 225M |
12/2021 | Solid Power | Post-IPO Equity | 0 |
4/2022 | Salsify | Series F | 0 |
3/2022 | A24 | Private Equity Round | 0 |
11/2020 | Menlo Security | Series E | 100M |
7/2017 | FV Hospital | Private Equity Round | - |
7/2022 | Supermojo | Seed Round | 0 |
4/2021 | Signifyd | Series E | 205M |
4/2015 | Prosper Marketplace | Series D | 0 |
5/2022 | Clutch | Debt Financing | 0 |
8/2020 | Fanatics | Series E | 350M |
8/2022 | Celonis | Series D | 0 |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
2/2020 | Level | Debt Financing | 100M |
2/2021 | SolarWinds | Post-IPO Equity | - |
8/2021 | Volta Charging | Post-IPO Equity | 300M |
12/2011 | Counsyl | Private Equity Round | 54M |
2/2022 | Scipher Medicine | Series D | 0 |
7/2021 | Owlet Baby Care | Post-IPO Equity | 130M |
6/2020 | Trustly | Venture Round | - |
6/2021 | Proterra | Post-IPO Equity | 415M |
5/2016 | Parag Milk Foods | Venture Round | 0 |
3/2015 | LookingGlass Cyber Solutions | Series B | 20M |
5/2021 | Caris Life Sciences | Private Equity Round | 0 |
3/2018 | CommonBond | Series D | 50M |
8/2021 | Li-Cycle | Post-IPO Equity | 0 |
10/2021 | PharmEasy | Venture Round | 0 |
12/2019 | Duck Creek Technologies | Private Equity Round | 120M |
9/2020 | Skillz | Post-IPO Equity | 0 |
8/2017 | LookingGlass Cyber Solutions | Series D | 26.3M |
6/2021 | Katapult | Post-IPO Equity | 150M |
10/2020 | DoubleVerify | Private Equity Round | 350M |
4/2022 | Quantum | Post-IPO Equity | 67.5M |
1/2022 | Savage X Fenty | Series C | 0 |
5/2021 | Akili Interactive Labs | Series D | 0 |
10/2020 | Caris Life Sciences | Private Equity Round | 0 |
4/2020 | AvidXchange | Series F | 128M |
7/2022 | Supermojo | Seed Round | 0 |
5/2022 | Clutch | Debt Financing | 0 |
4/2022 | Quantum | Post-IPO Equity | 0 |
4/2022 | Salsify | Series F | 0 |
3/2022 | A24 | Private Equity Round | 0 |
2/2022 | Scipher Medicine | Series D | 0 |
1/2022 | Savage X Fenty | Series C | 0 |
12/2021 | Solid Power | Post-IPO Equity | 0 |
12/2021 | Pear Therapeutics | Post-IPO Equity | 0 |
10/2021 | PharmEasy | Venture Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|